This is a Delaware news story, published by Yahoo, that relates primarily to AstraZeneca news.
For more Delaware news, you can click here:
more Delaware newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
blockbuster cancer drug Imfinzi. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest drug patents news, FDA news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
other cancer drugsReuters
•79% Informative
AstraZeneca 's shares hit all-time highs for the fourth -straight session on Thursday .
Shares hit record high of 130.48 pounds , taking its market capitalisation to about 202 billion pounds ( $259 billion ) The Anglo -Swedish drugmaker late on Wednesday convinced a federal judge in Delaware to throw out a jury's decision that the company owes $107.5 million for infringing cancer-drug patents.
VR Score
90
Informative language
98
Neutral language
34
Article tone
formal
Language
English
Language complexity
67
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links